Skip to main content

Your search for “Dementia” returned 126 results

Practice Imperfect: Repeated Cognitive Testing Can Obscure Early Signs of Dementia

July 11, 2018

…diagnosis and treatment. In a paper in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, researchers led by scientists at the University of California San Diego School of Medicine found that repeated testing of middle-age men produced a “practice effect” which obscured true cognitive decline and delayed detection of MCI.

New Therapeutic Target Identified for ALS and Frontotemporal Degeneration

November 8, 2013

…muscle movement, and frontotemporal degeneration, the second most frequent dementia.

Down Syndrome Research Untangles Therapeutic Possibilities for Alzheimer’s

September 17, 2015

…study confirms the pathogenic role of beta amyloid in dementia as seen in both AD and Down syndrome.

Novel Approaches to Treating Alzheimer’s Disease Include Early Intervention

May 15, 2012

Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.

New Virtual Reality Navigation System to Help Diagnose Cognitive Defects

August 18, 2014

Experts agree that the ability to navigate a neighborhood or built space is one of the first human faculties to suffer at the onset of cognitive decline. They also agree that early intervention is crucial for stemming the further ravages of dementia.

Participants in Dementia Prevention Research Motivated by Altruism

October 5, 2018

Researchers at University of California San Diego School of Medicine, with collaborators across the country, report that people who participate in dementia prevention trials are primarily motivated by altruism and pleased to help.

Alzheimer’s Cognitive Decline Slows in Advanced Age

August 2, 2012

The greatest risk factor for Alzheimer’s disease (AD) is advancing age. By age 85, the likelihood of developing the dreaded neurological disorder is roughly 50 percent. But researchers at the University of California, San Diego School of Medicine say AD hits hardest among the “younger elderly” – people in their…

Current Screening Methods Miss Worrisome Number of Persons with Mild Cognitive Impairment

May 23, 2016

In a paper published in the current Journal of Alzheimer’s Disease, researchers at University of California San Diego School of Medicine and Veterans Affairs San Diego Healthcare System say existing screening tools for mild cognitive impairment (MCI) result in a false-negative error rate of more than 7 percent. These persons…

UC San Diego Launches Unprecedented Down Syndrome Study

December 16, 2013

Down syndrome (DS) is a childhood condition but improved health care means that individuals with DS now routinely reach age 50 or 60 years of age, sometimes beyond. However, if they live long enough, people with Down syndrome are almost certain to develop Alzheimer’s disease.

New Drug Screening Method Answers Why Alzheimer’s Drugs Fail, Suggests New Targets

January 27, 2022

A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer’s disease.

Category navigation with Social links